Medtronic annual shareholders’ equity
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Medtronic Shareholders’ Equity Growth & History (MDT)
Medtronic's shareholders’ equity was $49.46B for fiscal 2026.
View full Medtronic company overviewMedtronic annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $49.46B | $1.44B | +3.00% |
| 2025 | 2025-04-25 | $48.02B | −$2.19B | −4.36% |
| 2024 | 2024-04-26 | $50.21B | −$1.27B | −2.46% |
| 2023 | 2023-04-28 | $51.48B | −$1.07B | −2.03% |
| 2022 | 2022-04-29 | $52.55B | $1.12B | +2.18% |
| 2021 | 2021-04-30 | $51.43B | $691.0M | +1.36% |
| 2020 | 2020-04-24 | $50.74B | $646.0M | +1.29% |
| 2019 | 2019-04-26 | $50.09B | −$629.0M | −1.24% |
| 2018 | 2018-04-27 | $50.72B | $512.0M | +1.02% |
| 2017 | 2017-04-28 | $50.21B | −$1.85B | −3.56% |
| 2016 | 2016-04-29 | $52.06B | −$1.17B | −2.19% |
| 2015 | 2015-04-24 | $53.23B | $33.79B | +173.77% |
| 2014 | 2014-04-25 | $19.44B | $772.0M | +4.13% |
| 2013 | 2013-04-26 | $18.67B | — | — |
Medtronic quarterly shareholders’ equity
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $50.23B | $2.34B | +4.88% |
| Q4 2026 | 2026-04-24 | $49.46B | $1.44B | +3.00% |
| Q3 2026 | 2026-01-31 | $48.98B | −$402.0M | −0.81% |
| Q3 2026 | 2026-01-23 | $48.98B | −$402.0M | −0.81% |
| Q2 2026 | 2025-10-24 | $48.65B | $158.0M | +0.33% |
| Q1 2026 | 2025-07-25 | $47.89B | −$54.0M | −0.11% |
| Q4 2025 | 2025-04-25 | $48.02B | −$2.19B | −4.36% |
| Q3 2025 | 2025-01-24 | $49.39B | −$2.40B | −4.64% |
| Q2 2025 | 2024-10-25 | $48.49B | −$2.97B | −5.76% |
| Q1 2025 | 2024-07-26 | $47.95B | −$3.23B | −6.31% |
| Q4 2024 | 2024-04-26 | $50.21B | −$1.27B | −2.46% |
| Q3 2024 | 2024-01-26 | $51.79B | $351.0M | +0.68% |
| Q2 2024 | 2023-10-27 | $51.46B | −$420.0M | −0.81% |
| Q1 2024 | 2023-07-28 | $51.18B | −$1.49B | −2.84% |
| Q4 2023 | 2023-04-28 | $51.48B | −$1.07B | −2.03% |
| Q3 2023 | 2023-01-27 | $51.44B | −$1.10B | −2.10% |
| Q2 2023 | 2022-10-28 | $51.88B | −$111.0M | −0.21% |
| Q1 2023 | 2022-07-29 | $52.67B | $1.19B | +2.30% |
| Q4 2022 | 2022-04-29 | $52.55B | $1.12B | +2.18% |
| Q3 2022 | 2022-01-28 | $52.54B | $1.78B | +3.51% |
| Q2 2022 | 2021-10-29 | $51.99B | $1.83B | +3.64% |
| Q1 2022 | 2021-07-30 | $51.49B | $1.19B | +2.37% |
| Q4 2021 | 2021-04-30 | $51.43B | $691.0M | +1.36% |
| Q3 2021 | 2021-01-29 | $50.76B | −$1.05B | −2.03% |
| Q2 2021 | 2020-10-30 | $50.16B | −$414.0M | −0.82% |
| Q1 2021 | 2020-07-31 | $50.30B | −$67.0M | −0.13% |
| Q4 2020 | 2020-04-24 | $50.74B | $646.0M | +1.29% |
| Q3 2020 | 2020-01-24 | $51.81B | $1.98B | +3.97% |
| Q2 2020 | 2019-10-25 | $50.58B | $971.0M | +1.96% |
| Q1 2020 | 2019-07-26 | $50.36B | $139.0M | +0.28% |
| Q4 2019 | 2019-04-26 | $50.09B | −$629.0M | −1.24% |
| Q3 2019 | 2019-01-25 | $49.83B | −$405.0M | −0.81% |
| Q2 2019 | 2018-10-26 | $49.61B | −$1.86B | −3.62% |
| Q1 2019 | 2018-07-27 | $50.22B | −$448.0M | −0.88% |
| Q4 2018 | 2018-04-27 | $50.72B | $512.0M | +1.02% |
| Q3 2018 | 2018-01-26 | $50.23B | $847.0M | +1.72% |
| Q2 2018 | 2017-10-27 | $51.47B | $1.28B | +2.56% |
| Q1 2018 | 2017-07-28 | $50.67B | −$152.0M | −0.30% |
| Q4 2017 | 2017-04-28 | $50.21B | −$1.85B | −3.56% |
| Q3 2017 | 2017-01-27 | $49.39B | −$1.43B | −2.81% |
| Q2 2017 | 2016-10-28 | $50.19B | −$2.08B | −3.99% |
| Q1 2017 | 2016-07-29 | $50.82B | −$1.99B | −3.76% |
| Q4 2016 | 2016-04-29 | $52.06B | −$1.17B | −2.19% |
| Q3 2016 | 2016-01-29 | $50.82B | $50.85B | — |
| Q2 2016 | 2015-10-30 | $52.27B | — | — |
| Q1 2016 | 2015-07-31 | $52.81B | — | — |
| Q4 2015 | 2015-04-24 | $53.23B | — | — |
| Q3 2015 | 2015-01-23 | −$37.0M | — | — |
Medtronic shareholders’ equity trends
Over the last five fiscal years, Medtronic's shareholders’ equity decreased from $51.43B to $49.46B, a change of −$1.97B. The latest reported quarter, Q1 2027, shows $50.23B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...